BioSpace News Archive

Genetown

Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference

Sigilon Therapeutics, Inc. today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the Needham Virtual Healthcare Conference.

April 18, 2023

·

1 min read

Identifai-Genetics Closes a Post-Seed Fundraising Round of USD 3.3M; Dr. Susan Gross, former CMO at Natera, named as Chief Strategic Advisor

Identifai-Genetics announced today that it has completed a post-seed fundraising round of USD 3.3M.

April 18, 2023

·

3 min read

BioCapital

REGENXBIO Announces Presentation at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will present in a fireside chat at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Tuesday, April 25, 2023 at 9:30 a.m. ET.

April 18, 2023

·

1 min read

BioMidwest

Xeris Biopharma Announces Issuance of U.S. Patent Covering XeriSol™ Formulations

Xeris Biopharma Holdings, Inc. today announced that the U.S. Patent and Trademark Office has issued US Patent Number 11,590,205, entitled ‘ METHODS FOR PRODUCING STABLE THERAPEUTIC GLUCAGON FORMULATIONS IN APROTIC POLAR SOLVENTS .’

April 18, 2023

·

5 min read

Genetown

Verastem Oncology to Present at the Stifel 2023 Virtual Targeted Oncology Days

Verastem Oncology today announced that the Company will present at the Stifel 2023 Virtual Targeted Oncology Days on Tuesday, April 25, 2023 at 2:30 p.m. ET.

April 18, 2023

·

1 min read

Business

Sonendo, Inc. to Report First Quarter 2023 Financial Results on May 9, 2023

Sonendo, Inc. today announced that it will report financial results for the first quarter 2023 after the market close on Tuesday, May 9th , 2023.

April 18, 2023

·

2 min read

Appili Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Appili Therapeutics Inc. today announced that Dr. Don Cilla, Appili President and Chief Executive Officer, will present at the Bloom Burton & Co. Healthcare Investor Conference taking place on April 25 and 26, 2023.

April 18, 2023

·

3 min read

BioCapital

OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel

OpGen, Inc. today announced that it has submitted a De Novo classification request to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for its Unyvero UTI Urinary Tract Infection (UTI) panel, following successful completion of its clinical trial.

April 18, 2023

·

5 min read

Pharm Country

Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader

Intelligent Bio Solutions Inc., a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced that the Company has been granted a patent in the United Kingdom relating to its Intelligent Fingerprinting Drug Screening System DSR-Plus Cartridge Reader.

April 18, 2023

·

5 min read

Kane Biotech Announces Additional coactiv+™ Animal Health Licensing Agreement

Kane Biotech Inc. announces that it has signed a licensing agreement with Skout’s Honor Pet Supply Company for its patented coactiv+™ technology in pet oral care applications.

April 18, 2023

·

5 min read